Ella Willenbacher
Innsbruck Medical University(AT)Universität Innsbruck(AT)University Hospital Innsbruck(AT)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)333 cited
- → T cells in multiple myeloma display features of exhaustion and senescence at the tumor site(2016)320 cited
- → Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera(2015)178 cited
- → Curcumin: New Insights into an Ancient Ingredient against Cancer(2019)149 cited
- → A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma(2016)66 cited
- → Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2b(2014)53 cited